Pharmacovigilance Documents

BC-CfE Pharmacovigilance 2016 Annual Report

SAFETY UPDATE: Antiretroviral drug interactions with non-prescription medications

SAFETY UPDATE: Nevirapine 400 mg XR (Viramune XR™) tablet remnants in feces

SAFETY ALERT: DARUNAVIR (PREZISTA TM)

SAFETY ALERT: RITONAVIR AND INTRA-ARTICULAR TRIMCINOLONE ACETONIDE INJECTION

SAFETY WARNING: ABACAVIR USE IN HLA-B*5701 POSITIVE PATIENTS AND UNTESTED PATIENTS

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

Start typing and press enter to search